← Search

Data · dataset · 2025

Selumetinib

Listed in Virginia Open Data Portal

Koselugo (selumetinib) is a prescription oral medication manufactured by AstraZeneca Pharmaceuticals LP.

Description

It acts as a kinase inhibitor, targeting MEK1 and MEK2 enzymes. Available in capsule forms (10mg and 25mg) and granules (equivalent to 5mg and 7.5mg base), it's used to treat certain conditions like neurofibromatosis type 1 in children.

This information was generated using AI and is provided for informational and research purposes only. --- ### 🔗 Related Datasets - Selumetinib — *HealthData.Gov* - Imatinib mesylate — *HealthData.Gov* - Imatinib mesylate — *HealthData.Gov* - Nilotinib — *HealthData.Gov* - Nilotinib — *HealthData.Gov* ---

Links

Where it is published

Documentation and papers

Catalogue records · 1

Topics

Provenance · 1 source records, 7 field assertions
SourceKeyLast seenRaw
Virginia Open Data Portale0ee7070-251d-40b9-ab34-78cd71ace12a6 h agoJSON v1
FieldAssertionExtractorEvidence
concepts[field].anzsrc:group:4206mapping · data virginia govvocabulary-mapper@1.0.0keywords['public-health']
concepts[field].local:field:medicine-healthmapping · data virginia govconnector:data_virginia_gov@1.0.0
created_datesource · data virginia govconnector:data_virginia_gov@1.0.0
descriptionsource · data virginia govconnector:data_virginia_gov@1.0.0/notes
publication_datesource · data virginia govconnector:data_virginia_gov@1.0.0
titlesource · data virginia govconnector:data_virginia_gov@1.0.0/title
updated_datesource · data virginia govconnector:data_virginia_gov@1.0.0